Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Taku Sakurai"'
Autor:
Hiroyuki Kato, Satoshi Yanagisawa, Taku Sakurai, Hisashi Murakami, Yasuya Inden, Toyoaki Murohara
Publikováno v:
Heart Rhythm O2. 4:329-332
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a594f56313c7ffa24dfaba3c40d45a0
https://doi.org/10.1016/j.hroo.2023.02.004
https://doi.org/10.1016/j.hroo.2023.02.004
Autor:
Toyoaki Murohara, Satoshi Yanagisawa, Hiroyuki Kato, Ryusuke Ota, Chiaki Mizuno, Kenji Kada, Ryo Watanabe, Yasuya Inden, Kazumasa Suga, Taku Sakurai, Takuya Okada, Hisashi Murakami, Naoya Tsuboi
Publikováno v:
JACC. Clinical electrophysiology. 8(1)
Objectives This study aimed to compare acute hemodynamic improvements and responses to His bundle pacing (HBP) and conventional biventricular pacing (BVP). Background HBP can correct left bundle branch block (LBBB) and may be an alternative cardiac r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7457d28cab88dd2bc1324c3a3c5fb131
https://pubmed.ncbi.nlm.nih.gov/35057980
https://pubmed.ncbi.nlm.nih.gov/35057980
Autor:
Richard J. Davenport, Sarah Bousba, Mathew Leveridge, David Harrison, Junji Matsui, Taku Sakurai, Louise Dickson, Kazumasa Ogawa, Matt Barnes, Stephen Robert Mack, Johannes Grosse, Parmar Alka, Laura Parton, Jennifer Cameron, Andy Sykes, Stuart Stafford
Publikováno v:
European Journal of Pharmacology. 727:1-7
GPR81, which exhibits a high degree of homology with GPR109a, has been recently identified as a lactate receptor. Similar to GPR109a, the activation of GPR81 by lactate suppresses lipolysis, suggesting that GPR81 may be a potential drug target for tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93662ada30b352aaba9afd5483b1214c
https://doi.org/10.1016/j.ejphar.2014.01.029
https://doi.org/10.1016/j.ejphar.2014.01.029
Publikováno v:
Pharmacology. 93:244-252
Background/Aims: The MT2 melatonin receptor is a potential target for treating circadian rhythm sleep disorders. This study aims to characterize the recently identified MT2 melatonin receptor agonist. Methods: The pharmacological properties of the MT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ac58e64dc0aa99fd87a7d64d7f0d4a5
https://doi.org/10.1159/000362561
https://doi.org/10.1159/000362561
Autor:
Seyed-Milad Hashemi-Hezaveh, Hong Shen, Yuh-Chiang Shen, Wei Xiao, Philip Wenzel, Kaihua Fan, Druckerei Stückle, Jun Sun, Yoshio Tanaka, Jyh-Fei Liao, Jinhong Hu, Tao Yang, Catalina Elena Lupusoru, Jianwen Gu, Kathrin Schwierczek, Keisuke Kanai, Raoul Vasile Lupusoru, Thomas Münzel, Xiaoyan Xiao, Ming-Kuan Chou, Xixiao Yang, Guangfu Yin, Hadi Sheidadoust, Chieh-Fu Chen, Dirk Sartor, Dibbanti Harikrishna Reddy, Taku Sakurai, Douglas L. Hainz, Amanda Pfeffer, Iulian Stoleriu, Maike Knorr, Michael Hausding, Karl Burgin, Shi-Kwang Lin, Kerstin Jurk, Lacramioara Ochiuz, Kyosuke Sato, Mao Ping, Seiji Miyauchi, Eberhard Schulz, E.G. Popa, Wei Dou, Liliana Tartau, Mandel Z. Manson, Keisuke Obara, Yea-Hwey Wang, Fadhil G. Al-Amran, Tommaso Gori, Junhai Zhang, Armin Scherhag, Matthias Oelze, Liqian Mo, Swenja Kröller-Schön, Tennent K. Hanley, Taiki Sugimoto, Tatsuki Koike, Anahita Torkaman-Boutorabi, Daisuke Chino, Shaolian Song, Mohammad-Reza Zarrindast, Shubham Misra, Yi-Kuei Wong, Waijiao Tang, Andreas Daiber, Masaharu Nakayama, Jie Ma, Jiin-Cherng Yen, Thomas Jansen, Bikash Medhi, Sun Ku Lee
Publikováno v:
Pharmacology. 93:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78d634ffe7f27323cdf8803951942206
https://doi.org/10.1159/000366576
https://doi.org/10.1159/000366576
Publikováno v:
Pharmacology. 93(5-6)
The MT₂ melatonin receptor is a potential target for treating circadian rhythm sleep disorders. This study aims to characterize the recently identified MT₂ melatonin receptor agonist.The pharmacological properties of the MT₂ melatonin receptor-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84f6627288317c4604b2afd4cebdabe3
https://pubmed.ncbi.nlm.nih.gov/25059758
https://pubmed.ncbi.nlm.nih.gov/25059758